FDA clears Prodigy thrombectomy system from Imperative Care subsidiary Truvic

Truvic Medical, a subsidiary of Imperative Care, announced today that it won FDA 510(k) clearance for its Prodigy thrombectomy system.

Campbell, California-based Truvic — which was acquired by Imperative Care in July 2021 — designed the Prodigy thrombectomy system for the treatment of peripheral vascular thrombus.

Prodigy is used to redefine peripheral vascular thrombus management by enabling single-session thrombus removal without the use of thrombolytics, according to a news release.

“We are excited to receive FDA clearance for our first thrombectomy system. We look forward to working with experts in the field to translate Prodigy’s novel design elements and features into superb clinical outcomes,” Truvic CEO Mike Buck said in the release. “This represents our first regulatory milestone as part of our strategy to advance multiple programs designed to meet patients’ needs and bring more innovative technologies to the market, faster.”

Read more
  • 0

Imperative Care raises $260M Series D for stroke care tech, acquires Truvic Medical

Imperative Care announced today that it closed a $260 million Series D financing round to support its stroke care technologies.

Campbell, Calif.-based Imperative Care had its funding led by D1 Capital Partners, with new investors HealthCor Investments and Innovatus Capital Partners also joining the round. Existing investors Ally Bridge Group, Bain Capital Life Sciences, Ascension Ventures, Delos Capital, Rock Springs Capital and Amed Ventures participated.

As a result of the financing, James Rogers of D1 Capital Partners will join Imperative Care’s board of directors, according to a news release.

The company said it earmarked proceeds from the financing for the support of the ongoing commercialization and development efforts across its portfolio of stroke care technologies. Additionally, funds will be used to create a strategic network of wholly-owned development subsidiaries in a range of areas.

“We are grateful for the confidence our inves…

Read more
  • 0